Back to
CITADEL ADVISORS LLC
ACAD31 quarters
Position history for
CITADEL ADVISORS LLC's holdings in ACADIA PHARMACEUTICALS INC
CITADEL ADVISORS LLC holds 2.2M shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $55.2M as of 2026-Q2. The position was increased (+250.4% shares). ACAD represents 0.0% of CITADEL ADVISORS LLC's portfolio.
Current Value
$55.2M
Current Shares
2.2M
Total Value Change
+$9.3M
Total Shares Change
-656,745
Quarter-by-Quarter History
Other major holders of ACAD: BAKER BROS. ADVISORS LP